KORU Medical Systems, Inc. (NASDAQ:KRMD) Shares Bought by Meros Investment Management LP

Meros Investment Management LP grew its holdings in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) by 20.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 804,380 shares of the company’s stock after buying an additional 137,918 shares during the period. Meros Investment Management LP owned 1.75% of KORU Medical Systems worth $2,132,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also made changes to their positions in the company. First Light Asset Management LLC lifted its stake in KORU Medical Systems by 1.1% during the first quarter. First Light Asset Management LLC now owns 5,220,990 shares of the company’s stock worth $12,322,000 after purchasing an additional 57,253 shares during the last quarter. Archon Capital Management LLC lifted its position in shares of KORU Medical Systems by 6.2% during the 1st quarter. Archon Capital Management LLC now owns 3,951,393 shares of the company’s stock worth $9,325,000 after buying an additional 230,517 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of KORU Medical Systems by 2.7% during the 1st quarter. Vanguard Group Inc. now owns 1,961,764 shares of the company’s stock worth $4,630,000 after buying an additional 51,890 shares during the last quarter. Lakewood Asset Management LLC boosted its holdings in shares of KORU Medical Systems by 13.9% in the 2nd quarter. Lakewood Asset Management LLC now owns 68,225 shares of the company’s stock valued at $181,000 after buying an additional 8,300 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of KORU Medical Systems in the 2nd quarter valued at $107,000. 58.60% of the stock is owned by institutional investors and hedge funds.

KORU Medical Systems Price Performance

KRMD stock opened at $2.70 on Friday. The company has a market cap of $123.80 million, a price-to-earnings ratio of -9.64 and a beta of 0.42. The company has a fifty day moving average price of $2.44 and a 200 day moving average price of $2.35. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.77 and a quick ratio of 3.27. KORU Medical Systems, Inc. has a 12 month low of $1.98 and a 12 month high of $3.09.

KORU Medical Systems (NASDAQ:KRMD) last announced its earnings results on Wednesday, August 7th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.02. The business had revenue of $8.43 million during the quarter, compared to the consensus estimate of $7.52 million. KORU Medical Systems had a negative net margin of 38.16% and a negative return on equity of 20.82%. During the same quarter in the prior year, the firm earned ($0.05) earnings per share. Sell-side analysts expect that KORU Medical Systems, Inc. will post -0.13 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have issued reports on KRMD shares. B. Riley assumed coverage on shares of KORU Medical Systems in a research note on Thursday, July 25th. They issued a “buy” rating and a $4.00 price objective for the company. Piper Sandler upped their target price on KORU Medical Systems from $2.50 to $3.00 and gave the company an “overweight” rating in a research report on Thursday, August 8th.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.